BlackRock Investment Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $665K | Buy |
86,206
+282
| +0.3% | +$2.18K | ﹤0.01% | 2914 |
|
|
2016
Q3 | $982K | Buy |
85,924
+22,967
| +36% | +$262K | ﹤0.01% | 2668 |
|
|
2016
Q2 | $775K | Buy |
62,957
+3,792
| +6% | +$46.7K | ﹤0.01% | 2803 |
|
|
2016
Q1 | $598K | Buy |
59,165
+10
| +0% | +$101 | ﹤0.01% | 2811 |
|
|
2015
Q4 | $1.33M | Buy |
59,155
+466
| +0.8% | +$10.5K | ﹤0.01% | 2377 |
|
|
2015
Q3 | $974K | Sell |
58,689
-1,334
| -2% | -$22.1K | ﹤0.01% | 2616 |
|
|
2015
Q2 | $1.35M | Buy |
60,023
+23,087
| +63% | +$520K | ﹤0.01% | 2544 |
|
|
2015
Q1 | $952K | Buy |
36,936
+392
| +1% | +$10.1K | ﹤0.01% | 2547 |
|
|
2014
Q4 | $795K | Sell |
36,544
-416
| -1% | -$9.05K | ﹤0.01% | 2694 |
|
|
2014
Q3 | $700K | Buy |
36,960
+855
| +2% | +$16.2K | ﹤0.01% | 2759 |
|
|
2014
Q2 | $841K | Buy |
36,105
+22,598
| +167% | +$526K | ﹤0.01% | 2719 |
|
|
2014
Q1 | $455K | Buy |
13,507
+696
| +5% | +$23.4K | ﹤0.01% | 2983 |
|
|
2013
Q4 | $378K | Buy |
12,811
+721
| +6% | +$21.3K | ﹤0.01% | 3070 |
|
|
2013
Q3 | $185K | Buy |
+12,090
| New | +$185K | ﹤0.01% | 3183 |
|